article thumbnail

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Pharmaceutical Commerce

According to the 2024 Edelman Trust Barometer, 2 most respondents believe that when industry leaders speak on health topics, their statements are often perceived as “false or gross exaggerations.”

article thumbnail

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

Standard-of-care treatment for patients with ALK fusions is alectinib (Alecensa; Genentech), a TKI that was approved by the FDA in 2024 for adjuvant treatment following tumor resection in patients with ALK-positive NSCLC. April 18, 2024. Updated August 9, 2024. Accessed June 19, 2025. Accessed June 19, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How automation and digital technologies will unlock the full potential of advanced therapies

European Pharmaceutical Review

In 2024, he became Chief Technology Officer, focusing on digital, automation and technology strategies. Dr Ward holds degrees from the University of Birmingham and Southampton University Medical School and serves as Vice-Chair of the Medicines Manufacturing Industry Partnership.

article thumbnail

Did You Fail the Pediatric Boards?

Board Vitals - Pharmacist

According to the American Board of Pediatrics, in 2024, 89% of first-time test takers passed the pediatric boards. Don’t waste your time with other things and don’t get detoured studying materials from medical school. Your experience and context from medical school will provide everything else you need.

article thumbnail

2024 Nobel Prize winner Gary Ruvkun on sharing credit and the future of microRNA

STAT

“I’ve won 10 to 20 awards in the last 20 years, but never had a press conference with cameras and nothing like this,” Ruvkun, who along with Victor Ambros received the 2024 award in medicine or physiology on Monday, said at a press conference at Massachusetts General Hospital.   Read the rest…

article thumbnail

STAT+: Equity, technology, and costs top of mind for life science’s leaders

STAT

Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List , which features 50 leaders in the life sciences. and the rest of the world.

article thumbnail

After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’

STAT

After having a day to read through the Supreme Court’s decision on affirmative action , some medical school and educational leaders are more hopeful that a path exists for them to diversify future classes and the health care workforce as they scramble to understand its impact on the next admissions cycle and the class of 2024.